Earn points on every order New products in stock Free 51-page beginner’s guide
← Back to Compound Library

EQUIPOISE (BOLDENONE)

A long-acting, “mild” anabolic steroid (originally veterinary) known for steady lean gains, increased appetite, and a big boost in red blood cells (endurance). Very long ester, takes weeks to kick in, so cycles run long. An anabolic steroid (oil), not a peptide.

Research referenceCommunity compiled

Molecular profile

The molecule itself: sequence, composition, mass, target, and registry identifiers.

Molecular formula
C₃₀H₄₄O₃
Average mass
452.7 Da
CAS number
13103-34-9
Registry
PubChem CID 11954310
Receptor / pathway
Androgen receptor
Formula, mass and identifiers from PubChem CID 11954310.
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Equipoise (Boldenone Undecylenate) is a long-acting veterinary injectable anabolic-androgenic steroid (AAS) structurally modified from testosterone.

What problem it targets: Originally developed for veterinary muscle wasting and debilitation, it is historically researched in bodybuilding for slow, steady lean muscle hypertrophy, vascularity, and appetite enhancement.

What It Does

• Promotes lean muscle protein synthesis: Binds intracellular androgen receptors to stimulate cellular nitrogen retention and accelerate muscle tissue rebuilding.

• Strongly stimulates red blood cell production (erythropoiesis): Stimulates kidney erythropoietin (EPO), substantially raising red blood cell count, hematocrit, and muscular endurance.

• Aromatizes at low rates: Converts to estradiol at roughly half the rate of testosterone, resulting in less water retention and leaner muscle gains, alongside marked appetite stimulation.

• Realistic expectations: Possesses a very long undecylenate ester half-life (~14 days), requiring several weeks to build steady blood concentrations. Carries significant risks of polycythemia (excessively thick blood) and cardiovascular strain.

Presentation

VialFormConcentrationNote
10 mLOil solution (no reconstitution)250 mg/mL0.1 mL = 25 mg. Very long ester, effects build over weeks.

Protocol

UseFrequencyDoseVolume (250 mg/mL)Notes
Cycle1–2×/week300–600 mg/week1.2–2.4 mL/week~300 mg/week is the floor to feel it. Run with a base testosterone.
Duration–––16+ weeks, the long ester needs a long cycle to show full effect. Cycle: 16+ weeks (long ester); pair with test. RBC: the standout effect, hematocrit can climb significantly; monitor and donate blood if needed. Note: controlled substance; suppresses natural testosterone, needs a base test and a PCT/recovery plan. Women: The long ester makes virilization especially dangerous, side effects persist for weeks and are hard to reverse. High virilization risk at any meaningful dose; generally avoided. Men: Slow-acting; notably raises red cells, watch hematocrit closely (donate blood if needed). Mild aromatization (monitor estradiol). Very long detection window.

Handling & Stacking

Injection site
IM. Rotate. Sterile technique.
Storage
Room temp, dark. Warm to clear if cold-clouded.
Side effects
Elevated hematocrit (the big one), increased appetite, mild estrogen rise, acne, hair loss (if predisposed), anxiety in some users. Generally fewer estrogenic sides than test.
What to expect
  • Slow, steady lean gains, better pumps/endurance, and appetite over a long cycle.
  • Not a dramatic mass builder, a quality/conditioning compound.
  • Supply math 10mL → ~4 weeks at 600 mg/wk, a 16-week cycle needs ~4 vials
Pairs well with
Testosterone (mandatory base); not with Trenbolone unless experienced (additive cardiovascular/RBC strain)
Avoid
High baseline hematocrit / polycythemia. Cardiovascular disease. Anxiety disorders (can worsen). Prostate/breast cancer. Pregnancy exposure

Safety & Patient Education

Contraindications
Polycythemia / elevated hematocrit (EQ raises RBC strongly) Cardiovascular disease Prostate or breast cancer Pregnancy (partner exposure)
Warnings
Pronounced high red-blood-cell count, clot/stroke risk; monitor hematocrit, may need blood donation HPTA suppression, requires a base testosterone and a recovery plan Adverse lipids and cardiovascular strain Anxiety/restlessness reported by some users Very long detection time and slow clearance
Drug interactions
Anticoagulants: bleeding/clotting balance altered, monitor Other RBC-raising agents: compounded polycythemia risk
Labs
  • CBC (hematocrit), especially important with EQ Lipids, estradiol, testosterone, PSA (age-appropriate), liver enzymes Blood pressure Out of range?
  • Hematocrit >54% = blood too thick (donate or hold); high estradiol = manage it; a rising PSA = get the prostate checked.
Stop criteria
Hematocrit >54% (or per clinician) Chest pain, severe headache, neurologic/vision changes Severe anxiety or cardiovascular symptoms
Patient education
Controlled steroid, run with a base testosterone, not solo Watch hematocrit closely, EQ’s signature risk is thick blood Long ester, be patient; cycles run 16+ weeks Have a recovery/PCT plan
References
researchdosing · PubMed · rxlist